NVAX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

31.65

Margin Of Safety %

Put/Call OI Ratio

0.46

EPS Next Q Diff

-0.09

EPS Last/This Y

-3.19

EPS This/Next Y

0.22

Price

9.21

Target Price

14.11

Analyst Recom

2.44

Performance Q

-1.6

Upside

-328.0%

Beta

2.37

Ticker: NVAX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	NVAX	8.15	0.53	0.19	210305
2026-04-24	NVAX	8.23	0.53	0.32	212877
2026-04-27	NVAX	8.06	0.56	0.28	199741
2026-04-28	NVAX	7.93	0.56	0.29	202172
2026-04-29	NVAX	7.99	0.56	0.21	204578
2026-04-30	NVAX	7.92	0.56	0.22	207955
2026-05-01	NVAX	8.03	0.55	0.45	209931
2026-05-04	NVAX	8.02	0.56	0.20	208033
2026-05-05	NVAX	8.11	0.55	0.08	211445
2026-05-06	NVAX	9.35	0.54	0.12	216279
2026-05-07	NVAX	9.23	0.53	0.22	226227
2026-05-08	NVAX	10.11	0.51	0.04	238885
2026-05-11	NVAX	9.5	0.45	0.14	254994
2026-05-12	NVAX	9.63	0.44	0.08	262836
2026-05-13	NVAX	9.24	0.43	0.07	270198
2026-05-14	NVAX	9.36	0.43	0.23	271315
2026-05-15	NVAX	9.07	0.44	0.10	274468
2026-05-18	NVAX	8.93	0.45	0.32	229666
2026-05-19	NVAX	8.91	0.45	0.84	236019
2026-05-20	NVAX	9.26	0.46	0.22	238150
2026-05-21	NVAX	8.98	0.45	0.12	241206
2026-05-22	NVAX	9.22	0.46	0.13	240919
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	NVAX	8.15	-110.9	-	-0.37
2026-04-24	NVAX	8.22	-110.9	-	-0.37
2026-04-27	NVAX	8.07	-110.9	-	-0.37
2026-04-28	NVAX	7.93	-110.9	-	-0.37
2026-04-30	NVAX	7.93	-110.9	-	-0.37
2026-05-01	NVAX	8.03	-110.9	-	-0.37
2026-05-04	NVAX	8.02	-110.9	-	-0.36
2026-05-05	NVAX	8.11	-110.9	-	-0.36
2026-05-06	NVAX	9.35	-110.9	-	-0.36
2026-05-07	NVAX	9.24	-110.9	-	-0.36
2026-05-08	NVAX	10.11	-110.9	-	-0.36
2026-05-11	NVAX	9.51	-110.9	-	-0.36
2026-05-12	NVAX	9.63	-48.4	-	-0.36
2026-05-13	NVAX	9.23	-48.4	-	-0.36
2026-05-14	NVAX	9.36	-167.7	-	-0.36
2026-05-15	NVAX	9.07	-167.7	-	-0.53
2026-05-18	NVAX	8.92	-167.7	-	-0.53
2026-05-19	NVAX	8.91	-167.7	-	-0.53
2026-05-20	NVAX	9.26	-167.7	-	-0.53
2026-05-21	NVAX	8.99	-167.7	-	-0.53
2026-05-22	NVAX	9.21	-167.7	-	-0.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	NVAX	0.00	7.91	29.04
2026-04-24	NVAX	0.00	7.91	29.04
2026-04-27	NVAX	0.00	7.53	29.91
2026-04-28	NVAX	0.00	7.53	29.91
2026-04-29	NVAX	0.00	7.53	29.91
2026-04-30	NVAX	0.00	7.53	29.91
2026-05-01	NVAX	0.00	7.53	29.91
2026-05-04	NVAX	0.00	2.66	29.91
2026-05-05	NVAX	0.00	2.66	29.91
2026-05-06	NVAX	0.00	2.66	29.91
2026-05-07	NVAX	0.00	2.66	29.91
2026-05-08	NVAX	0.00	2.66	29.91
2026-05-11	NVAX	0.00	2.58	29.64
2026-05-12	NVAX	0.00	2.58	31.65
2026-05-13	NVAX	0.00	2.58	31.65
2026-05-14	NVAX	0.00	2.58	31.65
2026-05-15	NVAX	0.00	2.58	31.65
2026-05-18	NVAX	0.00	0.95	31.65
2026-05-19	NVAX	0.00	0.95	31.65
2026-05-20	NVAX	0.00	0.95	31.65
2026-05-21	NVAX	0.00	0.95	31.65
2026-05-22	NVAX	0.00	0.95	31.65
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.4

Avg. EPS Est. Next Quarter

-0.15

Insider Transactions

Institutional Transactions

0.95

Beta

2.37

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

108

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.7

Max Drawdown 5-Year %

-98.6

Target Price

14.11

P/E

Forward P/E

PEG

P/S

2.54

P/B

P/Free Cash Flow

EPS

-0.6

Average EPS Est. Cur. Y

-0.47

EPS Next Y. (Est.)

-0.25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.73

Relative Volume

0.89

Return on Equity vs Sector %

33.6

Return on Equity vs Industry %

49.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.1

EBIT Estimation

◆ NVAX Healthcare

$9.21

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

20/20

Pullback

13/25

Volume

7/15

Valuation

10/20

TP/AR

3/10

Options

8/10

RSI

54.3

Range 1M

44.9%

Sup Dist

3.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

11/30

Estimates

2/20

Inst/Vol

4/15

Options

7/10

EPS Yr

-118.3%

EPS NY

46.1%

52W%

50.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +53.2% upside

Quality

7/30

Valuation

12/30

Growth

10/25

Stability

8/10

LT Trend

4/5

Upside

+53.2%

Quality

Novavax, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 749

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX

Latest News

—

Caricamento notizie per NVAX…

stock quote shares NVAX – Novavax, Inc. Stock Price stock today

news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NVAX – Novavax, Inc. yahoo finance google finance

stock history NVAX – Novavax, Inc. invest stock market

stock prices NVAX premarket after hours

ticker NVAX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y